Astria Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Astria Therapeutics generated cash of -$68,445,000, which is less than the previous year. Cash used in financing activities reached the amount of $88,398,000 last year. Net change in cash is therefore $155,005,000.
Cash Flow
| 2014 | -20.41M | -228K | 4.83M |
|---|---|---|---|
| 2015 | -29.79M | -421K | 78.32M |
| 2016 | -32.85M | -15.49M | 9.16M |
| 2017 | -26.83M | 14.88M | 4.72M |
| 2018 | -23.46M | -21.90M | 44.29M |
| 2019 | -26.56M | -4.08M | 25.62M |
| 2020 | -32.48M | 6.3M | 40.86M |
| 2021 | -30.15M | -12.55M | 104.28M |
| 2022 | -43.53M | -167.12M | 144.72M |
| 2023 | -68.44M | 135.05M | 88.39M |
ATXS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 20.68M | 86.62M | 25.05M | 10.37M | 15.40M | 16.48M | 23.59M | 62.78M | 14.66M | 30.47M |
Operating activities | ||||||||||
Net income | -72.89M | -51.83M | -194.91M | -37.3M | -26.29M | -25.87M | -27.36M | -36.06M | -32.63M | -21.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 26K | 119K | 304K | 395K | 202K | 248K |
Stock-based compensation expense | 6.31M | 4.55M | 3.36M | 1.39M | 1.51M | 0 | 2.00M | 2.16M | 1.65M | 897K |
| Deferred income tax benefit | 6.31M | 4.55M | 3.36M | 1.39M | 1.51M | 0 | 2.00M | 2.16M | 1.65M | 897K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 725K | -766K | -1.96M | 347K | -211K | 662K | -632K | 77K | 196K | 481K |
Cash generated by operating activities | -68.44M | -43.53M | -30.15M | -32.48M | -26.56M | -23.46M | -26.83M | -32.85M | -29.79M | -20.41M |
Investing activities | ||||||||||
Purchases Of Investments | -1.92B | -396.06M | -78M | -62.77M | -155.19M | -70.36M | -45.53M | -45.53M | 0 | -4.97M |
Investments In Property Plant And Equipment | -25K | -91K | -21K | -33K | -12K | 18K | -57K | -459K | -421K | -228K |
Acquisitions Net | 0 | 167.03K | 6.46M | -6.33K | 4.07K | -18K | 45.53M | 52K | 0 | 0 |
Cash generated by investing activities | 135.05M | -167.12M | -12.55M | 6.3M | -4.08M | -21.90M | 14.88M | -15.49M | -421K | -228K |
Financing activities | ||||||||||
Common Stock Issued | 87.97M | 144.63M | 104.28M | 40.82M | 25.56M | 47.13M | 8.03M | 11.99M | 61.74M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -2.84M | -3.33M | -3.33M | 4.16M | -5K |
Cash used in financing activities | 88.39M | 144.72M | 104.28M | 40.86M | 25.62M | 44.29M | 4.72M | 9.16M | 78.32M | 4.83M |
Net Change In Cash | 155.00M | -65.94M | 61.57M | 14.67M | -5.03M | -1.07M | -7.22M | -39.18M | 48.11M | -15.80M |
Cash at end of period | 175.69M | 20.68M | 86.62M | 25.05M | 10.37M | 15.40M | 16.36M | 23.59M | 62.78M | 14.66M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |